دورية أكاديمية

Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).

التفاصيل البيبلوغرافية
العنوان: Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
المؤلفون: Hirsh V, Cadranel J, Cong XJ, Fairclough D, Finnern HW, Lorence RM, Miller VA, Palmer M, Yang JC, Hirsh, Vera, Cadranel, Jacques, Cong, Xiuyu Julie, Fairclough, Diane, Finnern, Henrik W, Lorence, Robert M, Miller, Vince A, Palmer, Michael, Yang, James Chih-Hsin
المصدر: Journal of Thoracic Oncology; 2013 Feb, Vol. 8 Issue 2, p229-237, 9p
قاعدة البيانات: Complementary Index
الوصف
تدمد:15560864
DOI:10.1097/JTO.0b013e3182773fce